|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0205179,
umls-concept:C0242793,
umls-concept:C0600558,
umls-concept:C0681842,
umls-concept:C0729594,
umls-concept:C1517927,
umls-concept:C1522484,
umls-concept:C1609982
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-2-11
|
|
pubmed:abstractText |
This study was performed to validate the prognostic significance of residual axillary lymph node metastases in patients with locally advanced breast cancer (LABC) treated with neoadjuvant chemotherapy and to analyze other clinicopathologic factors that might be independent predictors of disease-free survival (DFS) in an attempt to identify patients in whom axillary dissection might be omitted.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0002-9610
|
|
pubmed:author |
pubmed-author:AmesF CFC,
pubmed-author:BinkleyS MSM,
pubmed-author:BuchholzT ATA,
pubmed-author:BuzdarA UAU,
pubmed-author:DhingraKK,
pubmed-author:FeigB WBW,
pubmed-author:HortobagyiG NGN,
pubmed-author:HuntK KKK,
pubmed-author:KuererH MHM,
pubmed-author:NewmanL ALA,
pubmed-author:RossM IMI,
pubmed-author:SingletaryS ESE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
176
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
502-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9926779-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9926779-Axilla,
pubmed-meshheading:9926779-Breast Neoplasms,
pubmed-meshheading:9926779-Cyclophosphamide,
pubmed-meshheading:9926779-Disease-Free Survival,
pubmed-meshheading:9926779-Doxorubicin,
pubmed-meshheading:9926779-Female,
pubmed-meshheading:9926779-Fluorouracil,
pubmed-meshheading:9926779-Humans,
pubmed-meshheading:9926779-Lymph Node Excision,
pubmed-meshheading:9926779-Lymph Nodes,
pubmed-meshheading:9926779-Lymphatic Metastasis,
pubmed-meshheading:9926779-Mastectomy, Segmental,
pubmed-meshheading:9926779-Middle Aged,
pubmed-meshheading:9926779-Neoadjuvant Therapy,
pubmed-meshheading:9926779-Patient Selection,
pubmed-meshheading:9926779-Prognosis
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.
|
|
pubmed:affiliation |
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
